SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-071054
Filing Date
2014-02-27
Accepted
2014-02-27 07:08:01
Documents
3
Period of Report
2014-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d684414d8k.htm 8-K 14497
2 EX-99.1 d684414dex991.htm EX-99.1 69317
3 GRAPHIC g684414ex99_1logo.jpg GRAPHIC 11786
  Complete submission text file 0001193125-14-071054.txt   101626
Mailing Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142 857-242-3700
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 14646668
SIC: 2834 Pharmaceutical Preparations